WSJ US BusinessModerna’s Covid-19 Vaccine Is 94.5% Effective in Early Results, Firm Says

November 16, 20200
http://www.gmi-co.com/wp-content/uploads/2020/11/modernas-covid-19-vaccine-is-94-5-effective-in-early-results-firm-says.jpg

Moderna Inc. said its experimental coronavirus vaccine was 94.5% effective at protecting people from Covid-19 in an early look at pivotal study results, the second vaccine to hit a key milestone in U.S. testing.

Ninety-five people in a 30,000-subject study developed Covid-19 with symptoms; of those, 90 had received a placebo and only five Moderna’s vaccine.

The…

Leave a Reply

Your email address will not be published. Required fields are marked *

700 Louisiana Street , Houston TX. 77002
(+1) 832-390-2738
info@gmi-co.com

Follow us:

FREE CONSULTATION

Calls may be recorded for quality and training purposes.

Copyright © GMI 2020